RICHELDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.587
EU - Europa 7.525
AS - Asia 6.370
SA - Sud America 961
AF - Africa 127
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 19
Totale 33.611
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.414
GB - Regno Unito 2.738
CN - Cina 2.149
SG - Singapore 1.934
IT - Italia 1.525
HK - Hong Kong 908
SE - Svezia 794
BR - Brasile 777
DE - Germania 565
UA - Ucraina 489
FI - Finlandia 386
VN - Vietnam 342
RU - Federazione Russa 333
TR - Turchia 302
FR - Francia 196
KR - Corea 195
BG - Bulgaria 166
IN - India 134
ID - Indonesia 106
CA - Canada 100
NL - Olanda 79
AR - Argentina 64
MX - Messico 53
ZA - Sudafrica 50
IE - Irlanda 41
BD - Bangladesh 33
EC - Ecuador 33
IQ - Iraq 32
PK - Pakistan 32
BE - Belgio 30
JP - Giappone 30
PL - Polonia 30
AT - Austria 26
IR - Iran 23
ES - Italia 22
UZ - Uzbekistan 21
NG - Nigeria 20
MY - Malesia 19
CO - Colombia 18
AE - Emirati Arabi Uniti 16
AU - Australia 16
PE - Perù 16
PY - Paraguay 16
AL - Albania 14
CH - Svizzera 13
CL - Cile 13
CZ - Repubblica Ceca 13
EU - Europa 13
TW - Taiwan 13
VE - Venezuela 12
LT - Lituania 11
MA - Marocco 11
TH - Thailandia 11
AZ - Azerbaigian 9
DZ - Algeria 9
SA - Arabia Saudita 9
JO - Giordania 8
KE - Kenya 8
DK - Danimarca 7
TN - Tunisia 7
EG - Egitto 6
PT - Portogallo 6
RO - Romania 6
AM - Armenia 5
BO - Bolivia 5
IL - Israele 5
LV - Lettonia 5
OM - Oman 5
UY - Uruguay 5
EE - Estonia 4
GR - Grecia 4
HN - Honduras 4
HR - Croazia 4
KG - Kirghizistan 4
NO - Norvegia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
A2 - ???statistics.table.value.countryCode.A2??? 3
ET - Etiopia 3
LB - Libano 3
PH - Filippine 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
BZ - Belize 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
JM - Giamaica 2
MG - Madagascar 2
PG - Papua Nuova Guinea 2
PS - Palestinian Territory 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 33.582
Salva come PNG Salva come JPEG
Città #
Fairfield 2.178
Southend 2.014
Santa Clara 1.601
Woodbridge 1.472
Ashburn 1.425
Singapore 1.220
Houston 1.143
Jacksonville 959
Chandler 921
Hong Kong 898
Seattle 821
Hefei 804
Dearborn 752
Wilmington 725
Ann Arbor 696
Cambridge 690
Nyköping 452
London 403
Beijing 374
Chicago 296
Los Angeles 258
Helsinki 214
San Diego 192
Modena 191
New York 178
Princeton 172
Sofia 164
Seoul 161
Eugene 158
The Dalles 141
Council Bluffs 129
Izmir 124
Salt Lake City 118
Buffalo 116
Ho Chi Minh City 110
Milan 94
Shanghai 88
Hanoi 83
Moscow 81
Dallas 70
Jakarta 70
Rome 64
Tampa 62
Naples 60
San Jose 60
São Paulo 58
Des Moines 57
Columbus 55
Palermo 51
Redwood City 49
Phoenix 47
Bremen 46
Elk Grove Village 43
Frankfurt am Main 40
Dublin 38
Boardman 34
Guangzhou 34
Sterling 32
Brussels 30
Florence 30
Norwalk 29
Montreal 28
San Francisco 28
Jersey City 27
Bari 26
Dong Ket 26
Turin 26
Atlanta 25
Chennai 25
Warsaw 25
Munich 23
Rio de Janeiro 23
Kunming 22
Boston 21
Detroit 21
Kent 20
Lancaster 20
Mumbai 20
Orem 20
Tashkent 20
Brooklyn 19
Falls Church 19
Philadelphia 19
San Mateo 19
Tokyo 19
Toronto 19
Denver 18
Long Branch 18
Miami 18
Leawood 17
Nanjing 16
Belo Horizonte 15
Haiphong 15
Jinan 15
Mexico City 15
Turku 15
Wuhan 15
Changsha 14
Chengdu 14
Lahore 14
Totale 24.454
Salva come PNG Salva come JPEG
Nome #
Malattie infiltrative diffuse del polmone 1.078
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 743
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. 425
Non-steroid agents for idiopathic pulmonary fibrosis 392
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 391
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure 377
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 355
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 351
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 347
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. 343
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients 338
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 337
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 322
Atypical lipomatous tumour (lipoma-like well-differentiated liposarcoma) arising in a pulmonary hamartoma and clinically presenting with pneumothorax 315
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 312
Aortic pulse wave velocity measurement in systemic sclerosis patients. 304
A culture-proven case of community-acquired Legionella pneumonia apparently classified as nosocomial: diagnostic and public health implications 296
Room size is the major determinant for tuberculin conversion in health care workers exposed to a multidrug-resistant tuberculosis patient 295
Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts 289
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study 283
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 281
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 279
Rifabutin for treating pulmonary tuberculosis. 271
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 269
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 264
Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis 263
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 262
A quantitative proteomic approach to identify significantly altered protein networks in the serum of patients with lymphangioleiomyomatosis (LAM) 261
Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection 260
Novel drug targets for idiopathic pulmonary fibrosis 257
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 255
Pulmonary fibrosis and the many faces of UIP 254
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 253
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 253
Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosis 252
Macrolides in the treatment of asthma and cystic fibrosis 251
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis 251
Amyotrophic lateral sclerosis and sarcoidosis: a difficult differential diagnosis. 248
An update on the diagnosis of tuberculosis infection 244
Emerging drugs for idiopathic pulmonary fibrosis. 242
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis 241
Early diagnosis of subclinical multi drug-resistant tuberculosis 240
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 240
Management of Idiopathic Pulmonary Fibrosis 240
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 240
Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials 239
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias 239
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 239
Smoking-related interstitial lung disease 236
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections 235
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management 234
Performance of commerical blood tests for the diagnosis of latent tuberculosis infection in children and adolescents 230
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay 227
Management of idiopathic pulmonary fibrosis. 227
Environmental triggers and susceptibility factors in idiopathic granulomatous diseases. 227
Unexpected identification of bilateral masses in an asymptomatic heavy smoker. 226
Blood tests for diagnosis of tuberculosis - Reply 225
Sarcoidosis: challenging diagnostic aspects of an old disease. 225
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 219
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis 217
The big clinical trials in idiopathic pulmonary fibrosis. 216
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 215
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. 214
Prevalence and prognosis of unclassifiable interstitial lung disease 212
Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy 209
Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis 205
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial 205
Macrolides for chronic asthma. 203
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis. 202
ANTIBODY REPERTOIRE AGAINST THE A60 ANTIGEN COMPLEX DURING THE COURSE OF PULMONARY TUBERCULOSIS 201
Identification Of Potential Candidate Biomarkers In Lymphangioleiomyomatosis Using ITRAQ Proteomic Technology 201
Challenges in idiopathic interstitial lung disease 200
Inappropriatezza prescrittiva dell'ossigenoterapia domiciliare a lungo termine 200
Tubercolosi 199
The complex interrelationships between chronic lung and liver disease: a review. 198
Immunomodulatory agents for idiopathic pulmonary fibrosis. 198
HLA-DPB1 Glutamate 69: a genetic marker of beryllium disease 197
MOLECULAR DIAGNOSIS OF TUBERCULOSIS 197
Role of the quantiferon-TB test in ruling out pleural tuberculosis: a multi-centre study. 197
Interferon gamma assays for tuberculosis 195
L'infezione tubercolare nel bambino: il contributo dei nuovi test immunologici 195
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 193
End of an ERA: lessons from negative clinical trials in idiopathic pulmonary fibrosis. 192
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. 191
Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease 191
Interaction of genetic and exposure factors in the prevalence of berylliosis 190
Genetic testing in diffuse parenchymal lung disease 188
Co-trimoxazole effect on human alveolar macrophages of AIDS patients 187
Tuberculosis infection in foreign-born children: a screening survey based on skin and blood testing. 185
Immunogenetic basis of environmental lung disease: lessons from the berylliosis model 184
The role of biomarkers in low respiratory tract infections. 184
Tuberculosis diagnostic tests: Sensitivity, specificity, and comparing apples with apples 183
Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis 182
Treating idiopathic pulmonary fibrosis: current opportunities and future challenges. 182
Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis 180
Mycobacterium tuberculosis induces CCL18 expression in human macrophages 180
Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection. 178
Levels Of Fibulin-1 In The Lung And Serum Are Increased In Fibrotic Interstitial Lung Disease 178
To BAL or not to BAL: is this a problem in diagnosing IPF? 177
Idiopathic pulmonary fibrosis: current challenges and future perspectives 177
Totale 25.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.891
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.022 0 0 0 0 0 262 292 444 165 417 243 199
2021/20222.903 86 488 275 221 59 87 200 108 293 208 525 353
2022/20232.694 324 274 169 241 317 402 47 292 331 81 116 100
2023/20242.023 62 129 124 173 372 244 245 244 67 47 128 188
2024/20255.889 212 90 84 417 1.236 847 389 367 631 357 585 674
2025/20266.301 676 489 1.084 1.283 1.747 1.022 0 0 0 0 0 0
Totale 33.810